nanoIMPAC: Monitoring immune toxicities and tumour immune evasion in lung cancer (2022–2025)

Grant type:
Cancer Australia
Researchers:
  • ARC Australian Laureate Fellow
    Australian Institute for Bioengineering and Nanotechnology
    ARC Laureate Fellow
    School of Chemistry and Molecular Biosciences
    Faculty of Science
  • NHMRC Emerging Leadership Fellow
    Australian Institute for Bioengineering and Nanotechnology
  • CSIRO Synthetic Biology Fellow
    Australian Institute for Bioengineering and Nanotechnology
Funded by:
Cancer Australia